AcquisitionOther
Gemini Therapeutics, Inc. /DE acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Gemini Therapeutics, Inc. /DE -> target · $53.5 million
(Disc), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases, announced today that they have entered into a definitive merger agreemen
Open source record (SEC) ↗